QA: Propanc Biopharma Inc. in us_pharma/2017

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001517681_2018_Propanc_Biopharma_Inc.pdf

Logs

warning Missing logo subcommand.report {}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0001517681')"}

Graph

Absolute values for 0001517681, Propanc Biopharma Inc.

  xvar xval
0 AssetsCurrent 81,976
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 10,790
3 remainder_Assets 2,303
4 LiabilitiesCurrent 5,536,820
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 4,739,431
9 ResearchAndDevelopmentExpense 971,769
10 remainder_Expenses -276,681
11 remainder_Revenues 0
12 remainder_NetIncome -2,432,981
13 remainder_ComprehensiveNetIncome -273,013
  yvar yval
0 Assets 95,069
1 Liabilities 5,536,820
2 Expenses 5,434,519
3 Revenues 0
4 StockholdersEquity -5,441,751
5 NetIncome -7,867,500
6 ComprehensiveNetIncome -8,004,006
7 BaseVar 6,886,201
8 EconomicCapitalRatio -6.17

Edgar->Model Mapping

Feature Distribution

Change over Time